Skip to main
MOH
MOH logo

Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare (MOH) Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 0%
Buy 25%
Hold 67%
Sell 8%
Strong Sell 0%

Bulls say

Molina Healthcare has demonstrated robust performance in its Medicare segment, with membership and revenue surpassing expectations, alongside a Medicare Medical Care Ratio (MCR) of 90.0% that reflects increased utilization in acute care populations. Despite facing pressures in its Medicaid business, the company's MCR of 91.3% still indicates resilience compared to historical trends, with specific challenges attributed to higher utilization among both new and renewing members. Additionally, the Marketplace segment showed unprecedented utilization growth, with an impressive MCR of 85.4% and significant quarterly increases, suggesting a strengthening position in a competitive landscape.

Bears say

Molina Healthcare's outlook for 2025 and 2026 has deteriorated significantly, driven by worsening marketplace trends and increasing medical cost pressures across its business segments. The company's second-quarter results prompted a downward revision of its fiscal year guidance, with adjusted EPS estimates for 2025 and 2026 now projected at $19.02 and $18.74, respectively, while earlier guidance suggested a minimum of $19.00. Additionally, over-reliance on Medicaid contracts in just four states, which cover more than half of its enrollees, presents heightened vulnerability to regulatory and economic changes in those markets.

Molina Healthcare (MOH) has been analyzed by 12 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 25% recommend Buy, 67% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Molina Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Molina Healthcare (MOH) Forecast

Analysts have given Molina Healthcare (MOH) a Hold based on their latest research and market trends.

According to 12 analysts, Molina Healthcare (MOH) has a Hold consensus rating as of Dec 17, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $205.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $205.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Molina Healthcare (MOH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.